TrialHuman vaccines & immunotherapeutics2020

Safety of the AS04-adjuvanted human papillomavirus (HPV)-16/18 vaccine in adolescents aged 12-15 years: end-of-study results from a community-randomized study up to 6.5 years.

Dan Bi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.